Does Strong NIH Research Support Mean Strong Career Development Funding?

A team compares the rankings of institutions with the largest amount of NIH research support with the highest-ranking institutions when it comes to support for training and career development.

5:00 AM

Author | Jina Sawani

Femal doctor using a pipette in lab
Getty image

Both mentorship and career development have been proven to increase the likelihood of a biomedical research trainee having a successful career. Less is known, however, about the impact of an academic institution on the training and career development support for its trainees. Also, research and training support may not necessarily go hand in hand, which is likely due to varying institutional priorities that may or may not proactively encourage trainees to seek their own independent support. 

A new research study from the University of Michigan and Rutgers University compares the rankings of institutions with the largest amount of research support from the National Institutes of Health, or NIH, with the highest-ranking institutions for NIH-acquired support for training and career development. The findings were recently published in JCI Insight, a journal published by the American Society for Clinical Investigation.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily updates on iTunes, Google Play and Stitcher. 

"If you are a young researcher with a mentor who is well funded, your mentor might not consider it a priority to encourage you to write fellowship or career development grants," says study co-lead Santiago Schnell, Phil (Oxon), FRSC, interim chair of molecular and integrative physiology at Michigan Medicine. "The mentor is clearly important, but the mentee contributes his or her own share, while the department or research unit also plays a critical role in the promotion of a culture that values and celebrates training and career awards."

The study examined total research and other NIH grant dollars awarded to academic medical centers in the United States from 2010 to 2018. Schnell adds that the NIH, the top biomedical research funding agency in the country, provides up-and-coming researchers and research institutions with support for fellowships, training and career development awards, and assistance with fundamental, translational and clinical research. These are typically the so-called NIH 'T,' 'K' and 'F' type grants.

MORE FROM THE LAB: Subscribe to our weekly newsletter

In 2020 alone, the NIH budget for biomedical research support was $41.6 billion.

"Our study was designed to help us understand if the overall research or training for T, K and F types of support go hand in hand," says study co-lead Marisa Conte, MLIS, associate director of research and informatics at the University of Michigan's Taubman Health Sciences Library. "Our analysis showed that, when averaged over the entire 2010 to 2018-time period of our study, there was a strong correlation between training and total NIH research support for the top seven schools. This no longer persisted for the schools ranked eight through 14."  

The U-M Medical School is consistently ranked in the top five institutions when it comes to T, K and F grants, though its total NIH funding is ninth.

"The U-M Medical School has been a long-standing national leader in supporting the career development and training of its learners," says Bishr Omary, M.D., PhD, a member of the research team who is also the senior vice chancellor for academic affairs and research at Rutgers Biomedical and Health Sciences, as well as the past executive vice dean for research at Michigan Medicine. "We knew this about U-M when we began our analysis, but did not appreciate how varied research institutions are in fostering the environment that supports individual and institutional garnering of T, K and F grants."

When averaged over the entire 2010 to 2018-time period of our study, there was a strong correlation between training and total NIH research support for the top seven schools. This no longer persisted for the schools ranked eight through 14.
Marisa Conte, MLIS

The team found that although the top 14 ranked institutions in research funding included the same top 14 ranked institutions in T, K and F support, only five institutions showed identical rankings of the 14, total. The remaining nine institutions ranked higher or lower on average. 

"This was an interesting finding of the study," says Schnell. "If you are a trainee, you would benefit by training at one of these five 'super-star' institutions or at institutions where you are likely to learn how to secure your own independent funding."

Therefore, the team's study highlighted the fact that training institutions and the NIH can better serve trainees.

"Our findings may alert institutions that have a high rank gap in overall NIH funding compared with training support to consider committing more resources to early career investigators and trainees," notes Schnell. "And institutions can increase their long-term footprints and impact in biomedical research by developing programs that help trainees successfully secure NIH K, F or other non-federal career awards."

Another important observation from the team's analysis is that the percent of NIH support for T, K and F grants (when compared with overall NIH support for research) has not kept up with an increasing NIH budget. Through further enhancing their critical role in research training and career development by allocating additional funds that are at least proportionate to their overall research support, Conte says that the NIH can better assist up-and-coming scientists and clinical trainees in the long run. 

"Biomedical research is critically important work for a variety of reasons, including its fundamental role in overcoming human disease. We must allocate the necessary investments to support the training of future generations of our biomedical workforce."

Paper cited: "Trends in NIH-supported career development funding: implications for institutions, trainees, and the future research workforce," JCI Insight. DOI: 10.1172/jci.insight.142817


More Articles About:

Med-U Education Hospitals & Centers Race and Ethnicity Social Status Health Care Delivery, Policy and Economics Demographics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Medicaid magnifying glass
Health Lab

What’s changing in Medicaid and what can you do?

With eligibility rules for people with lower incomes changing in every state, it’s important to stay up to date, seek trustworthy sources and not fall for misinformation
UMich Med Mosaic on blue background with colorful geometric shapes
UMich Med Mosaic

Beyond the White Coat: Disability, Neurodiversity and Advocacy in Medical School

In this episode of UMich Med Mosaic, host Mackenzie Kay sits down with medical students Jill Maudlin, Sarah Renberg and Bella Johnson to discuss their experiences as disabled and neurodivergent trainees at the University of Michigan Medical School. They reflect on the personal journeys that led them to medicine, the challenges and strengths that accompany living with disabilities and chronic health conditions and the importance of representation within the medical profession. The conversation explores how disability shapes their approaches to patient care, advocacy and teamwork, as well as the role of the Medical Students for Disability Health Advocacy (MSDHA) organization in creating community and advancing accessibility initiatives. They also discuss Michigan’s accommodations in medical education, efforts to improve disability-related curriculum content and the importance of building a culture where disabled and neurodivergent students can thrive.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
A hand holding a prescription bottle with a dollar bill in it
Health Lab

Top 7 tips for choosing Medicare prescription drug coverage for 2027

Prescription drug coverage through Medicare Advantage and Part D plans in traditional Medicare has changed for 2027, and older adults may not know about programs that could help with costs.
Well-Being at Michigan Medicine with Dr. Elizabeth Harry
Well-Being at Michigan Medicine

Learning Together: Making Space for Growth at Work

What if well-being starts with how we learn together? On this episode of Well-Being at Michigan Medicine, Elizabeth Harry, M.D., is joined by Rajesh Mangrulkar, M.D., FNAP, Executive Director of U-M’s Center for Interprofessional Practice and Education (IPE), Executive Director of Michigan Medicine RISE (Research. Innovation. Scholarship. Education), and primary care physician of internal medicine whose work focuses on organizational leadership and innovation, and Johnny McGraw, M.A., Marketing & Communications Specialist for both RISE and IPE, about building teams through human connection, psychological safety and learning. They discuss a meeting practice, why leaders shape culture and how investments in collaboration can help health care teams work without asking people to carry everything alone.
Purple shaded illustration of doctor listening to heart of patient on a bed
Health Lab

The AI is listening: Implications of machine generated clinical notes on health care

Michigan Medicine experts argue that use of artificial intelligent scribes during health care visits should be more carefully examined .